The Institute for Bioengineering of Catalonia (IBEC), a BIST centre, and the European Molecular Biology Laboratory (EMBL) aim to strengthen future collaboration between the two research institutions. To that end, IBEC Director Josep Samitier and EMBL Director Edith Heard have signed a 5-year agreement at the EMBL Barcelona headquarters, located in the Barcelona Biomedical Research Park (PRBB). The Centre for Genomic Regulation (CRG), another BIST centre, is also located in the PRBB and has also established a partnership with EMBL.
The Institute for Bioengineering of Catalonia (IBEC), a BIST centre, and the European Molecular Biology Laboratory (EMBL) aim to strengthen future collaboration between the two research institutions. To that end, IBEC Director Josep Samitier and EMBL Director Edith Heard have signed a 5-year agreement at the EMBL Barcelona headquarters, located in the Barcelona Biomedical Research Park (PRBB). The Centre for Genomic Regulation (CRG), another BIST centre, is also located in the PRBB and has also The IBEC-EMBL collaboration is the beginning of a working framework for activities between the two institutes which support strategic long-term scientific and general collaboration in areas of mutual interest. Some of the proposed joint projects include an EMBL-IBEC postdoc programme and a series of EMBL-IBEC seminars. Moreover, the institutes plan to reinforce visitors’ exchange whereby scientific personnel affiliated with EMBL or IBEC will have the possibility to visit the facilities of the other institution in order to study research developments and techniques and to foster interdisciplinary collaborations.
“We are delighted to start our collaboration with EMBL fostering interdisciplinary and international research” says Josep Samitier.
On February 10th-12th, 2020 IBEC and EMBL have organized a Winter Conference on Engineering multicellular systems. This conference will focus on how engineering multicellular living systems is boosting our understanding of tissue and organ function, with applications in disease modelling, drug screening, and tissue engineering. The symposium will take place at the La Pedrera Auditorium, one of Gaudí’s architectural masterpieces in Barcelona, and will be organized by James Sharpe, Head of EMBL-Barcelona and Xavier Trepat, IBEC Group Leader.
EMBL is an intergovernmental organization for the life sciences established in 1974 and funded by 23 member states, including Spain. Research at EMBL emphasizes experimental analysis at multiple levels of biological organization, from the molecule to the organism, as well as computational biology, bioinformatics and systems biology. Research is conducted by more than 80 independent groups covering the spectrum of molecular biology with more than 1700 employees from different nations.
IBEC is a cutting-edge multidisciplinary research centre that conducts excellent interdisciplinary research at the frontiers of basic and life sciences linked with engineering to generate new knowledge and applications by putting together biophysics, cell engineering, nanomedicine, biomaterials, tissue engineering and the applications of the information technology to health. The knowledge that exists in the IBEC research groups is placed at the service of science and society to progress in three major application areas: bioengineering for active aging, bioengineering for future medicine and bioengineering for regenerative therapies.
More information can be found on the IBEC website.
